Antidepressants Medications and the Relative Risk of Suicide Attempt
This study was conducted on patients (n=1283) of different ages, 924 males and 359 female. These patients were attended to poison unit at emergency hospital, Mansoura University during the period from January 2002 to December 2009. The aim of this study was to characterize patients on antidepressant...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Medknow Publications & Media Pvt Ltd
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339244/ |
| id |
pubmed-3339244 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-33392442012-06-25 Antidepressants Medications and the Relative Risk of Suicide Attempt Mandour, R. A. Original Article This study was conducted on patients (n=1283) of different ages, 924 males and 359 female. These patients were attended to poison unit at emergency hospital, Mansoura University during the period from January 2002 to December 2009. The aim of this study was to characterize patients on antidepressants after self-poisoning with suicidal intent regarding age, sex, type of current antidepressant therapy, and type of substances ingested in order to commit suicide. During the study period, 175 Para suicide patients were found with current antidepressants therapy and presented with self-poisoning using their antidepressant therapy or other medications. A substantial difference between different types of antidepressants was found. Para suicide risks for selective serotonin reuptake inhibitor were significantly low than those of tricyclic antidepressants, so in suicide prevention, risks and benefits of an antidepressant should be taken into account when choosing treatment for depressive patients. At the same time, depressed patients should be under close psychiatric assessment in order to prevent such possible suicidal attempts. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3339244/ /pubmed/22736902 http://dx.doi.org/10.4103/0971-6580.94517 Text en Copyright: © Toxicology International http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Mandour, R. A. |
| spellingShingle |
Mandour, R. A. Antidepressants Medications and the Relative Risk of Suicide Attempt |
| author_facet |
Mandour, R. A. |
| author_sort |
Mandour, R. A. |
| title |
Antidepressants Medications and the Relative Risk of Suicide Attempt |
| title_short |
Antidepressants Medications and the Relative Risk of Suicide Attempt |
| title_full |
Antidepressants Medications and the Relative Risk of Suicide Attempt |
| title_fullStr |
Antidepressants Medications and the Relative Risk of Suicide Attempt |
| title_full_unstemmed |
Antidepressants Medications and the Relative Risk of Suicide Attempt |
| title_sort |
antidepressants medications and the relative risk of suicide attempt |
| description |
This study was conducted on patients (n=1283) of different ages, 924 males and 359 female. These patients were attended to poison unit at emergency hospital, Mansoura University during the period from January 2002 to December 2009. The aim of this study was to characterize patients on antidepressants after self-poisoning with suicidal intent regarding age, sex, type of current antidepressant therapy, and type of substances ingested in order to commit suicide. During the study period, 175 Para suicide patients were found with current antidepressants therapy and presented with self-poisoning using their antidepressant therapy or other medications. A substantial difference between different types of antidepressants was found. Para suicide risks for selective serotonin reuptake inhibitor were significantly low than those of tricyclic antidepressants, so in suicide prevention, risks and benefits of an antidepressant should be taken into account when choosing treatment for depressive patients. At the same time, depressed patients should be under close psychiatric assessment in order to prevent such possible suicidal attempts. |
| publisher |
Medknow Publications & Media Pvt Ltd |
| publishDate |
2012 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339244/ |
| _version_ |
1611525673413771264 |